Objective: This study aimed to conduct objective and subjective comparisons of image quality among abdominal computed tomography (CT) reconstructions with deep learning reconstruction (DLR) algorithms, model-based iterative reconstruction (MBIR), and filtered back projection (FBP). Methods: Datasets from consecutive patients who underwent low-dose liver CT were retrospectively identified. Images were reconstructed using DLR, MBIR, and FBP. Mean image noise and contrast-to-noise ratio (CNR) were calculated, and noise, artifacts, sharpness, and overall image quality were subjectively assessed. Dunnett’s test was used for statistical comparisons. Results: Ninety patients (67 ± 12.7 years; 63 males; mean body mass index [BMI], 25.5 kg/m2) were included. The mean noise in the abdominal aorta and hepatic parenchyma of DLR was lower than that in FBP and MBIR (p < .001). For FBP and MBIR, image noise was significantly higher for obese patients than for those with normal BMI. The CNR for the abdominal aorta and hepatic parenchyma was higher for DLR than for FBP and MBIR (p < .001). MBIR images were subjectively rated as superior to FBP images in terms of noise, artifacts, sharpness, and overall quality (p < .001). DLR images were rated as superior to MBIR images in terms of noise (p < .001) and overall quality (p = .03). Conclusions: Based on objective and subjective comparisons, the image quality of DLR was found to be superior to that of MBIR and FBP on low-dose abdominal CT. DLR was the only method for which image noise was not higher for obese patients than for those with a normal BMI. Advances in knowledge: This study provides previously unavailable information on the properties of DLR systems and their clinical utility.
We aimed to compare the radiation dose and image quality of a low-dose abdominal computed tomography (CT) protocol reconstructed with deep learning reconstruction (DLR) with those of a routine-dose protocol reconstructed with hybrid-iterative reconstruction. This retrospective study enrolled 71 patients [61 men; average age, 71.9 years; mean body mass index (BMI), 24.3 kg/m 2 ] who underwent both low-dose abdominal CT with DLR [advanced intelligent clear-IQ engine (AiCE)] and routine-dose abdominal CT with hybrid-iterative reconstruction [adaptive iterative dose reduction 3D (AIDR 3D)]. Radiation dose parameters included volume CT dose index (CTDIvol), effective dose (ED), and size-specific dose estimate (SSDE). Mean image noise and contrast-to-noise ratio (CNR)were calculated. Image noise was measured in the hepatic parenchyma and bilateral erector spinae muscles. Moreover, subjective assessment of perceived image quality and diagnostic acceptability was performed. The low-dose protocol helped reduce the CTDIvol by 44.3%, ED by 43.7%, and SSDE by 44.9%. Moreover, the noise was significantly lower and CNR significantly higher with the low-dose protocol than with the normal-dose protocol (P<0.001). In the subjective assessment of image quality, there was no significant difference between the protocols with regard to image noise. Overall, AiCE was superior to AIDR 3D in terms of diagnostic acceptability (P=0.001). The use of AiCE can reduce overall radiation dose by more than 40% without loss of image quality compared to routine-dose abdominal CT with AIDR 3D.
In this report, we present a 57-year-old female with a history of mild alcoholic liver disease during a medical check-up. Abdominal computed tomography and magnetic resonance imaging showed a multicystic mass with a solid enhancing mural nodule in the right lobe of the liver. Subsequently, laparoscopic right liver lobectomy was performed and pathological findings revealed intraductal papillary neoplasm of the bile duct (IPNB) with an associated invasive carcinoma. IPNB is a relatively rare disease that should be considered in the differential diagnosis of hepatic cystic tumours. Our case report highlights the importance of capturing image findings of the IPNB as this disease has a high potential for malignancy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.